Skip to main content
Main menu
HOME
ONLINE FIRST
CURRENT ISSUE
ALL ISSUES
AUTHORS & REVIEWERS
SUBSCRIBE
CONFERENCE
MORE
About BJGP
Advertising
eLetters
Alerts
BJGP LIFE
Video
Audio
Librarian information
Resilience
COVID-19 Clinical Solutions
RCGP
BJGP for RCGP members
BJGP Open
RCGP eLearning
InnovAIT Journal
Jobs and careers
User menu
Subscriptions
Alerts
Log in
Search
Search for this keyword
Advanced search
Intended for Healthcare Professionals
RCGP
BJGP for RCGP members
BJGP Open
RCGP eLearning
InnovAIT Journal
Jobs and careers
Subscriptions
Alerts
Log in
Follow BJGP on LinkedIn
Follow bjgp on BlueSky
Visit bjgp on Facebook
Blog
Listen to BJGP podcast
Subscribe BJGP on YouTube
Visit bjgp on Instagram
Intended for Healthcare Professionals
Search for this keyword
Advanced Search
HOME
ONLINE FIRST
CURRENT ISSUE
ALL ISSUES
AUTHORS & REVIEWERS
SUBSCRIBE
CONFERENCE
MORE
About BJGP
Advertising
eLetters
Alerts
BJGP LIFE
Video
Audio
Librarian information
Resilience
COVID-19 Clinical Solutions
polypharmacy
Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?
Amaia
Calderón-Larrañaga
, et al
British Journal of General Practice
1 December 2012;
62
(605):
e821-e826.
DOI:
https://doi.org/10.3399/bjgp12X659295
Potential health impacts of multiple drug prescribing for older people: a case-control study
Umesh T
Kadam
British Journal of General Practice
1 February 2011;
61
(583):
128-130.
DOI:
https://doi.org/10.3399/bjgp11X556263
Effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings
, et al
British Journal of General Practice
1 January 2010;
60
(570):
e10-e19.
DOI:
https://doi.org/10.3399/bjgp09X473295
Pages
Previous
1
2
3
